The SFDA is the first regulatory authority globally to grant conditional approval for this medication for the treatment of NSCLC ...
Edoardo Bove is set to resume his career in England after signing a multi-year contract with Watford, following the mutual ...
The definition is tricky, but the effects of poor metabolic health are clear — and can wreak havoc on the body.
As Hollywood imagines our future, are brain and human microchip implants nearing a “ChatGPT moment” in 2026? Medical progress ...
The nightmare is finally over, Edoardo Bove will return to playing football. He will not do it in Italy but in England, at ...
Sarepta Therapeutics saw its stock skid 11% after the company announced preliminary unaudited 2025 sales results that missed analyst forecasts for its marketed Elevidys® (delandistrogene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results